Immunovant, Inc.

By person

18 insiders · 61 transactions

17.2×

Eric Venker holds 17.2 times base salary in stock. $11.00M of shares against $636.62K in salary for 2026.

Salary from the company's own proxy. The shares are what Eric Venker last reported holding, valued at $43.27, the price Common Stock was last bought or sold at on the open market here, on 28 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Roivant Sciences Ltd. entity

Director

$350.00M (1)

—

+$350.00M

113,317,007

54.86%

$4.90B

+42.0%

Fromkin Andrew J.

Director

—

$7.96M (4) scheduled

−$7.96M

74,382

0.0360%

$3.22M

−25.6%

Stout Jay S

Chief Technology Officer

—

$2.27M (15)

−$2.27M

205,341

0.0994%

$8.89M

+41.7%

Gloria Melanie

Chief Operating Officer

—

$1.60M (14)

−$1.60M

219,301

0.1062%

$9.49M

—

Girao Tiago

Chief Financial Officer

—

$1.41M (3)

−$1.41M

240,798

0.1166%

$10.42M

—

Van Tuyl Christopher

Chief Legal Officer

—

$1.31M (9) scheduled

−$1.31M

179,391

0.0868%

$7.76M

—

Venker Eric

Chief Executive Officer

—

$461.83K (3)

−$461.83K

254,280

0.1231%

$11.00M

—

Pande Atul

Director

—

$424.65K (5) scheduled

−$424.65K

116,731

0.0565%

$5.05M

+23.6%

Hughes Douglas J.

Director

—

$348.67K (2) scheduled

−$348.67K

134,653

0.0652%

$5.83M

+7.7%

Geffner Michael

Chief Medical Officer

—

$70.12K (2)

−$70.12K

217,958

0.1055%

$9.43M

+57.8%

Susman Robert Graham

Director

—

$67.98K (1) scheduled

−$67.98K

36,394

0.0176%

$1.57M

—

Salzmann Peter

Chief Executive Officer

—

1,178,191

0.5704%

$50.98M

+16.8%

Torti Frank

Director

—

1,009,228

0.4886%

$43.67M

+58.8%

Barnett Eva Renee

Chief Financial Officer

—

396,774

0.1921%

$17.17M

+15.4%

Macias William L.

Chief Medical Officer

—

357,353

0.1730%

$15.46M

−3.0%

Levine Mark S.

Chief Legal Officer

—

319,228

0.1546%

$13.81M

−3.3%

MIGAUSKY GEORGE V

Director

—

137,251

0.0664%

$5.94M

+13.4%

Bauer Jake

Director

—

38,896

0.0188%

$1.68M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Pande Atul

28 Aug 2026

Director

Sold after exercise

1,500

$43.27

$64.91K

Pande Atul

24 Jul 2026

Director

Sold after exercise

1,500

$39.80

$59.70K

Pande Atul

26 Jun 2026

Director

Sold after exercise

1,500

$38.01

$57.02K

Girao Tiago

26 Jun 2026

Chief Financial Officer

Sold after exercise

10,000

$38.46

$384.60K

Van Tuyl Christopher

26 Jun 2026

Chief Legal Officer

Sold after exercise

2,842

$38.96

$110.72K

Van Tuyl Christopher

26 Jun 2026

Chief Legal Officer

Sold after exercise

14,982

$38.19

$572.16K

Pande Atul

15 Jun 2026

Director

Sold after exercise

1,500

$34.02

$51.03K

Fromkin Andrew J.

28 May 2026

Director

Sold after exercise

210,468

$33.56

$7.06M

Fromkin Andrew J.

28 May 2026

Director

Sold after exercise

11,483

$32.64

$374.81K

Pande Atul

20 May 2026

Director

Sold after exercise

6,000

$32.00

$192.00K

Show all 61 transactions →

By person

Individual transactions

What was left out